secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICAD INC (—)
CIK:        0000749660
Form:       8-K
Filed at:   2023-10-23T23:59:59+00:00
Accession:  0001193805-23-001436
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.01, 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iCAD sells Xoft brachytherapy business to Elekta for $5.76M; Q3 rev est $5.4-$5.6M
--------------------------------------------------------------------------------

- Sold Xoft brachytherapy line to Elekta for ~$5.76M cash + assumed liabilities; closed Oct 22, 2023.
- Preliminary Q3 2023 revenue estimated $5.4M–$5.6M; operating expenses $5.5M–$5.7M.
- Pro forma shows Xoft contributed $3.1M revenue in H1 2023 and $8.1M in FY 2022.
- Net cash proceeds ~$4.83M after transaction costs; estimated gain on sale ~$2.64M.
- Three-year non-compete/non-solicit; transition services agreement for up to 5 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749660/000119380523001436/0001193805-23-001436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749660/000119380523001436/e618999_8k-icad.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-001436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer